QRL-201

· QurAlis Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QRL-201, covering 2025-08-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Tolerability of QRL-201 in ALS [Phase 1]